Subscribe to RSS
DOI: 10.1055/s-2007-969189
© Georg Thieme Verlag Stuttgart · New York
In-Vitro-5-Lipoxygenasehemmung durch Eclipta alba Extrakte und das Coumestan-Derivat Wedelolacton
In Vitro 5-Lipoxygenase Inhibition by Eclipta alba Extracts and the Coumestan Derivative WedelolactonePublication History
1986
Publication Date:
26 February 2007 (online)

Abstract
In the search for potent and selective 5-lipoxygenase-inhibitors, extracts of medicinal plants were screened for their potency of inhibiting the formation of inflammatory acting products of arachidonic acid metabolism using a porcine-leukocytes test system. The coumestan derivative wedelolactone isolated from Eclipta alba (L.) Hassk. and Wedelia calendulacea Less. has been found as a potent and selective 5-lipoxygenase-inhibitor with an IC50 of 2,5 µMol. As found by chemoluminescence, wedelolactone inhibits 5-lipoxygenase by an oxygen radical scavenger mechanism.